About this trial
Study population: Patients with liver cirrhosis complicated by sepsis Observation indicators: Fluid resuscitation strategy, early dynamic indicators such as MAP Observation endpoint: 28-day all-cause mortality Study design: Retrospective cohort study
Eligibility criteria
Qualifiers
Clinically or pathologically diagnosed with cirrhosis;
meets the Sepsis-3 diagnostic criteria.
Disqualifiers
Combined organ transplantation, active malignant tumors;
Pregnant or breastfeeding women;
Long-term use of immunosuppressants (non-steroidal);
Death or voluntary discharge within 24 hours of admission;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
Sponsors and collaborators
Source ClinicalTrials.gov